It’s an exciting time in the field of celiac disease! Research is suggesting that the gluten-free diet alone is not enoughto stay healthy for most people living with this serious genetic autoimmune condition. The U.S. Food and Drug Administration (FDA) is responding to the need for alternative therapies to treat celiac disease. On March 30-31, 2015, the FDA is hosting a landmark event focused on improving our treatment options: The Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT) 3 Workshop.

The National Foundation for Celiac Awareness (NFCA) is thrilled to be part of this momentous event. Members of the NFCA team will be in attendance, including President and CEO Alice Bast. Alice will represent the voice of our communitythrough a presentation focused on the unmet needs of those living with celiac disease.

Two GREAT Ways to Get Involved:

Listen In to the GREAT3 Workshop Live

Don’t miss a moment of the action! The FDA will allow people to remotely tune in to this landmark meeting. Learn more about the GREAT3 Workshop and how you can listen in.

Special Free Webinar from NFCA: The Future of Drug Therapy for Celiac Disease: Get the Honest Facts

Following the GREAT 3 Workshop, NFCA Director of Healthcare Initiatives, Kristin Voorhees, MA, will moderate a free webinar drawing together celiac disease experts and patients to give you the honest facts on celiac disease drug therapies, what they mean for you and why a treatment beyond only the gluten-free diet is needed.Learn more and register.